Benzinga
España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Benzinga
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Analyst Color
FDA Rejection Sparks Questions On Replimune Drug Approval Path
ON Semiconductor's $6 Billion Buyback, AI Growth Shift Narrative
Allogene Therapeutics Stock Hits 52-Week High - Here's Why
ON Semiconductor's $6 Billion Buyback, AI Growth Shift Narrative
Allogene Therapeutics Stock Hits 52-Week High - Here's Why
$4 Gas Is Draining American Wallets: Here's Why Pizza Stocks Could Actually Gain
Anthropic's Mythos Triggers Cybersecurity Race — CrowdStrike, Rubrik, Cloudflare Stand To Gain
$4 Gas Is Draining American Wallets: Here's Why Pizza Stocks Could Actually Gain
Anthropic's Mythos Triggers Cybersecurity Race — CrowdStrike, Rubrik, Cloudflare Stand To Gain
IBM Analyst Slashes Price Target Ahead Of Q1 Results, Lowers Q2 Estimates
Netflix Q1 Preview: Analyst Expects Ad Revenues To Exceed $3 Billion
Read More...
Analyst Color Recent News
Business Leaders Expect Tariffs To Persist Beyond Trump Era: Biden 'Did Not Remove' Trump Tariffs
PwC survey finds 86% of U.S. business leaders expect Trump-era tariffs to remain in place for years ahead.
Amazon, Meta, Levi Strauss And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week
Retail investors talked up five hot stocks this week (April 6 to April 10) on X and Reddit's r/WallStreetBets: AMZN, META, LEVI, PLTR, TSLA.
Anthropic, OpenAI And Big Tech's 'Number One Goal' Is To Kill OpenClaw, Says Venture Capitalist Jason Calacanis
Jason Calacanis says competitors are racing to overtake OpenClaw, highlighting growing rivalry in the AI agent space.
Jim Cramer Flags Overbought Stocks Amid Fragile Iran Truce As Wall Street Cheers: 'Bulls Need To Pull In Their Horns A Little Bit'
On Friday, Jim Cramer warned that markets may be overly optimistic after a ceasefire-driven rally between the U.S. and Iran.
Shopify Faces AI Disruption Fears, But JPMorgan Isn't Backing Down
Shopify's stock is down 30% YTD on fear of disruption from agentic commerce. JPMorgan analyst expects strong GMV and margin growth till 2028.
What's Going On With Simulations Plus Stock Friday?
Simulations Plus beats Q2 estimates, trims fiscal 2026 earnings outlook, and keeps sales guidance intact on favorable market conditions.
Chevron Q1 Earnings Will Be 'Noisy' As Headwinds Reverse To Tailwinds: Analyst
As Chevron prepares to report Q1 results on May 1, major oil producers are facing significant disruptions that offset potential gains.
Meta's Latest $21 Billion Move Could Help De-Risk CoreWeave's Growth: Analyst
CoreWeave (CRWV) lands $21B Meta expansion for AI inference. JPMorgan eyes revenue tailwinds but warns of macro volatility and power risks.
Inflation Panic Sends US Consumer Confidence To All-Time Low: University Of Michigan
Consumer confidence hit an all-time low of 47.6 in April as the Iran war drove year-ahead inflation expectations to 4.8%.
CoreWeave Stock's Momentum Score Spikes As $21 Billion Meta Deal Ignites Rally
CoreWeave (CRWV) momentum score spikes as a $21B Meta deal and new debt milestone fuel a massive rally. Citizens forecasts up to 96% upside.
Netflix Could Lift 2026 Operating Margin Guide: Analyst
Analyst predicts Netflix will raise 2026 margin outlook to 32% and maintain 12-14% revenue growth. Expects higher share repurchases.
Trump's Iran War Sends Gasoline To Biggest Monthly Surge Since 1967 — 6 Energy Stocks To Watch
Gasoline posted its biggest monthly CPI jump since 1967 in March, rising 21.2% as the Iran war closed the Strait of Hormuz.
Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady
FDA accepts Telix NDA for Pixclara for brain cancer imaging, analysts see confidence rebuild amid steady sales growth.
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started